Literature DB >> 17690225

Temperature influences the coordinated expression of myogenic regulatory factors during embryonic myogenesis in Atlantic salmon (Salmo salar L.).

Daniel J Macqueen1, David Robb, Ian A Johnston.   

Abstract

Potential molecular mechanisms regulating developmental plasticity to temperature were investigated in Atlantic salmon embryos (Salmo salar L.). Six orthologues of the four myogenic regulatory factors (MRFs: individually: smyf5, smyoD1a/1b/1c, smyoG and sMRF4), the master transcription factors regulating vertebrate myogenesis, were characterised at the mRNA/genomic level. In situ hybridisation was performed with specific cRNA probes to determine the expression patterns of each gene during embryonic myogenesis. To place the MRF data in the context of known muscle fibre differentiation events, the expression of slow myosin light chain-1 and Pax7 were also investigated. Adaxial myoblasts expressed smyoD1a prior to and during somitogenesis followed by smyoD1c (20-somite stage, ss), and sMRF4 (25-30 ss), before spreading laterally across the myotome, followed closely by the adaxial cells. Smyf5 was detected prior to somitogenesis, but not in the adaxial cells in contrast to other teleosts studied. The expression domains of smyf5, smyoD1b and smyoG were not confined to the s-smlc1 expression field, indicating a role in fast muscle myogenesis. From the end of segmentation, each MRF was expressed to a greater or lesser extent in zones of new muscle fibre production, the precursor cells for which probably originated from the Pax7 expressing cell layer external to the single layer of s-smlc1(+) fibres. SmyoD1a and smyoG showed similar expression patterns with respect to somite stage at three different temperatures investigated (2 degrees C, 5 degrees C and 8 degrees C) in spite of different rates of somite formation (one somite added each 5 h, 8 h and 15 h at 8 degrees C, 5 degrees C and 2 degrees C, respectively). In contrast, the expression of smyf5, sMRF4 and s-smlc1 was retarded with respect to somite stage at 2 degrees C compared to 8 degrees C, potentially resulting in heterochronies in downstream pathways influencing later muscle phenotype.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17690225     DOI: 10.1242/jeb.006981

Source DB:  PubMed          Journal:  J Exp Biol        ISSN: 0022-0949            Impact factor:   3.312


  6 in total

1.  Activity of metabolic enzymes and muscle-specific gene expression in parr and smolts Atlantic salmon Salmo salar L. of different age groups.

Authors:  Maria V Churova; Olga V Meshcheryakova; Aleksey E Veselov; Denis A Efremov; Nina N Nemova
Journal:  Fish Physiol Biochem       Date:  2017-03-18       Impact factor: 2.794

2.  Temperature until the 'eyed stage' of embryogenesis programmes the growth trajectory and muscle phenotype of adult Atlantic salmon.

Authors:  Daniel J Macqueen; David H F Robb; Tom Olsen; Linda Melstveit; Charles G M Paxton; Ian A Johnston
Journal:  Biol Lett       Date:  2008-06-23       Impact factor: 3.703

3.  Evolution of follistatin in teleosts revealed through phylogenetic, genomic and expression analyses.

Authors:  Daniel J Macqueen; Ian A Johnston
Journal:  Dev Genes Evol       Date:  2007-12-11       Impact factor: 0.900

4.  Genetic background and embryonic temperature affect DNA methylation and expression of myogenin and muscle development in Atlantic salmon (Salmo salar).

Authors:  Erik Burgerhout; Maren Mommens; Hanne Johnsen; Arnfinn Aunsmo; Nina Santi; Øivind Andersen
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

5.  Phasing of muscle gene expression with fasting-induced recovery growth in Atlantic salmon.

Authors:  Neil I Bower; Richard G Taylor; Ian A Johnston
Journal:  Front Zool       Date:  2009-08-24       Impact factor: 3.172

6.  An update on MyoD evolution in teleosts and a proposed consensus nomenclature to accommodate the tetraploidization of different vertebrate genomes.

Authors:  Daniel J Macqueen; Ian A Johnston
Journal:  PLoS One       Date:  2008-02-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.